| 1 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-2,09 % |
+21,56 % |
-0,19 |
| 2 |
LU1176839154 |
Protea Fund - Sectoral Biotech Opportunities Fund IF USD |
-2,11 % |
+21,09 % |
-0,19 |
| 3 |
LU1897414642 |
Janus Henderson Horizon Biotechnology Fund E2 USD |
-3,62 % |
+27,96 % |
-0,20 |
| 4 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-2,36 % |
+21,39 % |
-0,20 |
| 5 |
LU1897414568 |
Janus Henderson Horizon Biotechnology Fund IU2 USD |
-4,47 % |
+28,25 % |
-0,23 |
|
|
| 80 |
LU1991432631 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse (SEK) P-acc, SEK |
-17,13 % |
+23,90 % |
-0,80 |
|
|
| 86 |
LU1725387622 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating |
-15,87 % |
+14,13 % |
-1,26 |
| 87 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
-15,98 % |
+14,13 % |
-1,27 |
| 88 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
-16,56 % |
+14,12 % |
-1,31 |
| 89 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-19,26 % |
+14,96 % |
-1,42 |
| 90 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-19,82 % |
+14,96 % |
-1,46 |